| P50 | author | Alexander Ploner | Q54997547 |
| | Karin Sundström | Q63688593 |
| | Pär Sparén | Q89722137 |
| | Eva Herweijer | Q114432408 |
| P2860 | cites work | Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study | Q30682187 |
| | Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California | Q35051454 |
| | Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland | Q35678090 |
| | The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study | Q35719771 |
| | HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study | Q36662008 |
| | Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. | Q36734952 |
| | Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia. | Q37616577 |
| | Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance | Q37983132 |
| | Clinical trials of human papillomavirus vaccines and beyond | Q38111962 |
| | Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up | Q39514544 |
| | Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women | Q42236236 |
| | Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada | Q42244848 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 416-418 | |
| P577 | publication date | 2017-05-10 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Reply to Ryser et al | |
| P478 | volume | 141 | |